Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor

Fan Gao, Patrick M. Sexton, Arthur Christopoulos, Laurence J Miller

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The cholecystokinin (CCK1) receptor is a G protein-coupled receptor important for nutrient homeostasis. The molecular basis of CCK-receptor binding has been debated, with one prominent model suggesting occupation of the same region of the intramembranous helical bundle as benzodiazepines. Here, we used a specific assay of allosteric ligand interaction to probe the mode of binding of devazepide, a prototypic benzodiazepine ligand. Devazepide elicited marked slowing of dissociation of pre-bound CCK, only possible through binding to a topographically distinct allosteric site. This effect was disrupted by chemical modification of a cysteine in the benzodiazepine-binding pocket. Application of an allosteric model to the equilibrium interaction between a series of benzodiazepine ligands and CCK yielded quantitative estimates of each modulator's affinity for the allosteric site, as well as the degree of negative cooperativity for the interaction between occupied orthosteric and allosteric sites. The allosteric nature of benzodiazepine binding to the CCK1 receptor provides new opportunities for small molecule drug development.

Original languageEnglish (US)
Pages (from-to)4401-4404
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume18
Issue number15
DOIs
StatePublished - Aug 1 2008

Fingerprint

Cholecystokinin Receptors
Benzodiazepines
Modulators
Allosteric Site
Ligands
Devazepide
Cholecystokinin
Chemical modification
G-Protein-Coupled Receptors
Occupations
Nutrients
Cysteine
Assays
Homeostasis
Food
Molecules
Pharmaceutical Preparations

Keywords

  • Allosteric modulators
  • Cholecystokinin receptor
  • Cooperativity
  • G protein-coupled receptors

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor. / Gao, Fan; Sexton, Patrick M.; Christopoulos, Arthur; Miller, Laurence J.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 18, No. 15, 01.08.2008, p. 4401-4404.

Research output: Contribution to journalArticle

@article{7b1a3cfd8aeb496dbfdf378a691dbd22,
title = "Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor",
abstract = "The cholecystokinin (CCK1) receptor is a G protein-coupled receptor important for nutrient homeostasis. The molecular basis of CCK-receptor binding has been debated, with one prominent model suggesting occupation of the same region of the intramembranous helical bundle as benzodiazepines. Here, we used a specific assay of allosteric ligand interaction to probe the mode of binding of devazepide, a prototypic benzodiazepine ligand. Devazepide elicited marked slowing of dissociation of pre-bound CCK, only possible through binding to a topographically distinct allosteric site. This effect was disrupted by chemical modification of a cysteine in the benzodiazepine-binding pocket. Application of an allosteric model to the equilibrium interaction between a series of benzodiazepine ligands and CCK yielded quantitative estimates of each modulator's affinity for the allosteric site, as well as the degree of negative cooperativity for the interaction between occupied orthosteric and allosteric sites. The allosteric nature of benzodiazepine binding to the CCK1 receptor provides new opportunities for small molecule drug development.",
keywords = "Allosteric modulators, Cholecystokinin receptor, Cooperativity, G protein-coupled receptors",
author = "Fan Gao and Sexton, {Patrick M.} and Arthur Christopoulos and Miller, {Laurence J}",
year = "2008",
month = "8",
day = "1",
doi = "10.1016/j.bmcl.2008.06.053",
language = "English (US)",
volume = "18",
pages = "4401--4404",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "15",

}

TY - JOUR

T1 - Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor

AU - Gao, Fan

AU - Sexton, Patrick M.

AU - Christopoulos, Arthur

AU - Miller, Laurence J

PY - 2008/8/1

Y1 - 2008/8/1

N2 - The cholecystokinin (CCK1) receptor is a G protein-coupled receptor important for nutrient homeostasis. The molecular basis of CCK-receptor binding has been debated, with one prominent model suggesting occupation of the same region of the intramembranous helical bundle as benzodiazepines. Here, we used a specific assay of allosteric ligand interaction to probe the mode of binding of devazepide, a prototypic benzodiazepine ligand. Devazepide elicited marked slowing of dissociation of pre-bound CCK, only possible through binding to a topographically distinct allosteric site. This effect was disrupted by chemical modification of a cysteine in the benzodiazepine-binding pocket. Application of an allosteric model to the equilibrium interaction between a series of benzodiazepine ligands and CCK yielded quantitative estimates of each modulator's affinity for the allosteric site, as well as the degree of negative cooperativity for the interaction between occupied orthosteric and allosteric sites. The allosteric nature of benzodiazepine binding to the CCK1 receptor provides new opportunities for small molecule drug development.

AB - The cholecystokinin (CCK1) receptor is a G protein-coupled receptor important for nutrient homeostasis. The molecular basis of CCK-receptor binding has been debated, with one prominent model suggesting occupation of the same region of the intramembranous helical bundle as benzodiazepines. Here, we used a specific assay of allosteric ligand interaction to probe the mode of binding of devazepide, a prototypic benzodiazepine ligand. Devazepide elicited marked slowing of dissociation of pre-bound CCK, only possible through binding to a topographically distinct allosteric site. This effect was disrupted by chemical modification of a cysteine in the benzodiazepine-binding pocket. Application of an allosteric model to the equilibrium interaction between a series of benzodiazepine ligands and CCK yielded quantitative estimates of each modulator's affinity for the allosteric site, as well as the degree of negative cooperativity for the interaction between occupied orthosteric and allosteric sites. The allosteric nature of benzodiazepine binding to the CCK1 receptor provides new opportunities for small molecule drug development.

KW - Allosteric modulators

KW - Cholecystokinin receptor

KW - Cooperativity

KW - G protein-coupled receptors

UR - http://www.scopus.com/inward/record.url?scp=47749152194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47749152194&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2008.06.053

DO - 10.1016/j.bmcl.2008.06.053

M3 - Article

C2 - 18621527

AN - SCOPUS:47749152194

VL - 18

SP - 4401

EP - 4404

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 15

ER -